Synuclein-γ is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer

Clinical Cancer Research

Volumn 15, Issue 8, 2009, Pages 2864-2871

  Hibi, Taizo ^a,b,c   Mori, Taisuke ^a   Fukuma, Mariko ^a   Yamazaki, Ken ^a   Hashiguchi, Akinori ^a   Yamada, Taketo ^a   Tanabe, Minoru ^b   Aiura, Koichi ^b   Kawakami, Takao ^d   Ogiwara, Atsushi ^b   Kosuge, Tomoo ^c   Kitajima, Masaki ^b   Kitagawa, Yuko ^b   Sakamoto, Michiie ^a,b  

^a Department of Pathology ^*  (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RNA; SYNUCLEIN; SYNUCLEIN GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; TRANSCRIPTOMICS; UPREGULATION;

AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; FEMALE; FOLLOW-UP STUDIES; GAMMA-SYNUCLEIN; GENE SILENCING; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROGNOSIS; PROTEOMICS; RETROSPECTIVE STUDIES; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 65249187279     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2946     Document Type: Article

References (34)

1. JemalA, SiegelR,WardE, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Wray CJ,Ahmad SA,Matthews JB, Lowy AM.Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;128:1626-41.
3. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004;198:722-31.
4. SohnTA,Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-79.
5. Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer. Pancreas 2003;26:322-5.
6. Biankin AV, Morey AL, Lee CS, et al. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol 2002;20:4531-42.
7. Koide N, Yamada T, Shibata R, et al. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin Cancer Res 2006;12:2419-26.
8. Fu X, Guadagni F, Hoffman RM. A metastaticnude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 1992;89:5645-9.
9. Shevchenko A, Wilm M,Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996;68:850-8.
10. Maeda J, HiranoT, Ogiwara A, et al. Proteomic analysis of stage l primary lung adenocarcinoma aimed at individualisation of postoperative therapy. BrJ Cancer 2008;98:596-603.
11. Kawakami T,Tateishi K,YamanoY, IshikawaT, Kuroki K, Nishimura T. Protein identification from product ion spectra of peptides validated by correlation between measured and predicted elution times in liquid chromatography/mass spectrometry. Proteomics 2005;5:856-64.
12. Schwartz JC, Senko MW, Syka JE. A two-dimensional quadrupole ion trap mass spectrometer. J Am Soc Mass Spectrom 2002;13:659-69.
13. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
14. Japan Pancreas Society. Classification of pancreatic carcinoma. 2nd English ed. Tokyo: Kanehara; 2003.
15. Sobin LH,Wittekind CH. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 93-6.
16. Li Z, Sclabas GM, Peng B, et al. Overexpression of synuclein-gamma in pancreatic adenocarcinoma. Cancer 2004;101:58-65.
17. INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci 2007;98:147-54.
18. Naviaux RK, Costanzi E, Haas M,Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996;70:5701-5.
19. Liu H, Liu W,WuY, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-43.
20. Jia T, Liu YE, Liu J, Shi YE. Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res1999;59:742-7.
21. Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, MotoyamaT. Demethylation of the synuclein γ gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res 2004;10:2447-51.
22. Wu K, Quan Z, Weng Z, et al. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treat 2007;101:259-67.
23. JiangY, Liu YE, Goldberg ID, Shi YE. Gamma synuclein, a novel heat-shock protein-associated chaper-one, stimulates ligand-dependant estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Res 2004;64:4539-46.
24. Liu YE, Pu W, Jiang Y, Shi D, Dackour R, Shi YE. Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene 2007;26:2115-25.
25. Zhu Z, Friess H, diMola FF, et al. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. JClin Oncol 1999;17:2419-28.
26. Zhu ZW, Friess H, Wang L, et al. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001;7:105-12.
27. Pan ZZ, Breuning W, Giasson BI, LeeVM, Godwin AK. Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 2002;277:35050-60.
28. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE, Surguchov AP. Effect of γ-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 2003;410:167-76.
29. Bloomston M, Zervos EE, RosemurgyAS II. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 2002;9:668-74.
30. Buchman VL, Adu J, Pinon LG, Ninkina NN, Davies AM. Persyn, a member of the synuclein family,influences neurofilament network integrity. Nat Neurosci 1998;1:101-3.
31. Maccioni RB, Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev1995;75:835-64.
32. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004;64:9018-26.
33. Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro-Cacho CA, Yeatman TJ. Fibrinogen γ overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res 2006;66:2592-9.
34. Iwaki H, Kageyama S, Isono T, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma-synuclein, and catechol-o-meth-yltransferase) identified byproteomicanalysis. Cancer Sci 2004;95:955-61.